Rxsight Inc
NASDAQ:RXST

Watchlist Manager
Rxsight Inc Logo
Rxsight Inc
NASDAQ:RXST
Watchlist
Price: 12.54 USD -0.63% Market Closed
Market Cap: 515.6m USD

During the last 3 months Rxsight Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 36% over this period (open performance analysis).

The last transaction was made on Mar 12, 2025 by Fountain Tamara , who sold 180k USD worth of RXST shares.

Last Transactions:
Fountain Tamara
$-180k
Maniar Shweta
$-108.6k
Corley Jesse Anderson
$+55k
Corley Jesse Anderson
$+45k
Goldshleger Ilya
$-143.1k
Maniar Shweta
$-173.5k
Goldshleger Ilya
$-142.2k
Goldshleger Ilya
$-139.5k
Goldshleger Ilya
$-138k
Goldshleger Ilya
$-224.3k
Corley Jesse Anderson
$+250.7k
Goldshleger Ilya
$-61.4k
Corley Jesse Anderson
$+504.1k
Goldshleger Ilya
$-159.4k
Goldshleger Ilya
$-144.8k
Goldshleger Ilya
$-161.2k
Goldshleger Ilya
$-157k
Goldshleger Ilya
$-154.4k
Goldshleger Ilya
$-154k
Goldshleger Ilya
$-150.3k
Goldshleger Ilya
$-154.3k
Goldshleger Ilya
$-155.3k
Goldshleger Ilya
$-155.6k
Goldshleger Ilya
$-151.6k
Goldshleger Ilya
$-149.6k
Goldshleger Ilya
$-137.4k
Thunen Shelley B
$-249.4k
Goldshleger Ilya
$-80.4k
Goldshleger Ilya
$-153.1k
Goldshleger Ilya
$-155.2k
Goldshleger Ilya
$-164.9k
Goldshleger Ilya
$-173.9k
View All Transactions

During the last 3 months Rxsight Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 36% over this period (open performance analysis).

The last transaction was made on Mar 12, 2025 by Fountain Tamara , who sold 180k USD worth of RXST shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
288.6k USD
2
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
1
100k USD

Rxsight Inc
Insider Trading Chart

Rxsight Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Rxsight Inc
Last Insider Transactions

Global
Insiders Monitor

Rxsight Inc
Glance View

In the dynamic realm of ophthalmology, RxSight Inc. has carved a niche as a pioneering force in enhancing vision outcomes for cataract patients. At the heart of the company’s innovation is its Light Adjustable Lens (LAL) system. Traditional intraocular lenses (IOLs), once implanted, lock patients into a certain prescription, accepting only minimal adjustments. RxSight, with its groundbreaking technology, offers a solution that breaks this convention. Post-cataract surgery, the LAL allows ophthalmologists to precisely adjust the lens prescription using UV light, often yielding better visual acuity tailored to patient needs. This transformative approach turns the one-size-fits-all model of vision correction into a personalized patient experience, promising a brighter, clearer outlook on life. Commercially, RxSight operates within the medical device industry, focusing on capturing a significant share of the cataract surgery market—one of the most frequent surgeries performed worldwide. The company earns revenue primarily through the sale of its LAL system to eye care professionals and clinics. This business model is akin to a razor-and-blade approach; besides the initial sale of the adjustable lenses, RxSight garners continuous revenue from associated products and services, such as the light delivery device and follow-up adjustments required post-surgery. By addressing a substantial unmet need with a recurring revenue stream, RxSight strategically positions itself for growth within the burgeoning biotech sector, all while setting new benchmarks for patient satisfaction in eye care.

RXST Intrinsic Value
15.84 USD
Undervaluation 21%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top